CARLOS SOLANO VERCET-rekin lankidetzan egindako argitalpenak (11)

2017

  1. The impact of virus population diversity on the dynamics of cytomegalovirus DNAemia in allogeneic stem cell transplant recipients

    Journal of General Virology, Vol. 98, Núm. 10, pp. 2530-2542

2016

  1. Would kinetic analyses of plasma cytomegalovirus DNA load help to reach consensus criteria for triggering the initiation of preemptive antiviral therapy in transplant recipients?

    Clinical Infectious Diseases

2010

  1. Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFN CD8 and CD4 T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients

    Bone Marrow Transplantation, Vol. 45, Núm. 3, pp. 543-549

2008

  1. Enumeration of cytomegalovirus-specific interferong CD8+ and CD4+ T cells early after allogeneic stem cell transplantation may identify patients at risk of active cytomegalovirus infection

    Haematologica

  2. Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients

    Journal of Clinical Microbiology, Vol. 46, Núm. 10, pp. 3311-3318

2005

  1. Prophylaxis of early bacterial infections after autologous peripheral blood stem cell transplantation (PBSCT): A matched-pair study comparing oral fluoroquinolones and intravenous piperacillin-tazobactam

    Bone Marrow Transplantation, Vol. 36, Núm. 1, pp. 59-65

2003

  1. Reconstitution of lymphocyte populations and cytomegalovirus viremia or disease after allogeneic peripheral blood stem cell transplantation

    Journal of Medical Virology, Vol. 70, Núm. 3, pp. 399-403

2001

  1. Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation

    Journal of Clinical Microbiology, Vol. 39, Núm. 11, pp. 3938-3941

  2. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine

    Journal of Medical Virology, Vol. 65, Núm. 1, pp. 178-184

1999

  1. Complicaciones asociadas a catéteres venosos centrales en pacientes con neoplasias hematológicas o trasplante hematopoyético

    Sangre, Vol. 44, Núm. 3, pp. 171-175

1996

  1. Engraftment failure associated with peripheral blood stem cell transplantation after B19 parvovirus infection [2]

    Blood